DOI:
10.1055/s-00000019
Fortschritte der Neurologie · Psychiatrie
LinksClose Window
References
Loo H, Hale A, D'haenen H.
Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study.
Int Clin Psychopharmacol 2002; 17: 239-247
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.